Drug factory · FDA FEI 2522445
Noramco, LLC
500 Swedes Landing Road, Wilmington, DE, United States
Problems found, fixed voluntarily at FDA's last inspection, Oct 15, 2025.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
8 drug inspections on record since 2010: 5 with no problems, 3 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Amphetamine | Makes the active ingredient | Aurolife Pharma LLC | 13107-259, 13107-260 |
| Morphine | Makes the active ingredient | Caraco Pharmaceutical Laboratories, Ltd. | 63304-450, 63304-451, 63304-452 +2 |
| Naloxone | Makes the active ingredient | Uswm, LLC | 78670-140 |
| Oxycodone | Makes the active ingredient | Knoa Pharma LLC | 59011-410, 59011-415, 59011-420 +4 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Oct 15, 2025 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Nov 18, 2022 | No problems found | Drug Quality Assurance | — |
| Feb 21, 2019 | No problems found | Drug Quality Assurance | — |
| Nov 17, 2017 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Jan 21, 2016 | No problems found | Drug Quality Assurance | — |
| Nov 13, 2014 | No problems found | Drug Quality Assurance | — |
| Apr 27, 2012 | No problems found | Drug Quality Assurance | — |
| Aug 2, 2010 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
Registered with FDA for: api manufacture; particle size reduction; repack.